MeSH term
Frequency | Condition_Probility | Humans | 94 | 0.0 |
Adult | 14 | 0.0 |
Cadherins/analysis | 2 | 6.0 |
Disease Progression | 3 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 12 | 0.0 |
Fluorescent Antibody Technique, Direct | 4 | 3.0 |
Male | 27 | 0.0 |
Amino Acid Sequence | 11 | 0.0 |
Animals | 37 | 0.0 |
Binding Sites | 3 | 0.0 |
Blister/*etiology | 2 | 100.0 |
Kinetics | 3 | 0.0 |
Mice | 20 | 0.0 |
Molecular Sequence Data | 23 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 69 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 25 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Cadherins/*genetics | 8 | 8.0 |
*Genes, MHC Class II | 2 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Pemphigus/*genetics/immunology | 2 | 50.0 |
Amino Acid Sequence/genetics | 2 | 0.0 |
Base Sequence/genetics | 2 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Cytoskeletal Proteins/*genetics | 7 | 6.0 |
DNA, Complementary/genetics | 5 | 0.0 |
Exons | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Multigene Family/*genetics | 2 | 1.0 |
Autoantibodies/*analysis | 4 | 1.0 |
Cadherins/*immunology | 23 | 71.0 |
Pemphigus/*genetics/*immunology | 2 | 66.0 |
Phenotype | 6 | 0.0 |
Autoantibodies/*immunology | 4 | 1.0 |
*Epitope Mapping | 2 | 3.0 |
Point Mutation | 3 | 0.0 |
Autoimmunity/*immunology | 2 | 4.0 |
Disease Models, Animal | 4 | 0.0 |
Autoantigens | 2 | 6.0 |
Cell Adhesion Molecules/immunology | 2 | 2.0 |
Cytoskeletal Proteins/immunology | 3 | 60.0 |
Desmosomes/immunology | 5 | 83.0 |
Diagnosis, Differential | 4 | 0.0 |
Adolescent | 6 | 0.0 |
Aged | 15 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Female | 22 | 0.0 |
Middle Aged | 17 | 0.0 |
Cadherins/chemistry/genetics/*metabolism | 2 | 66.0 |
Cell Line | 6 | 0.0 |
Comparative Study | 10 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Desmosomes/*metabolism | 6 | 42.0 |
Solubility | 2 | 0.0 |
Fatal Outcome | 2 | 0.0 |
Autoantigens/immunology | 7 | 5.0 |
Autoimmune Diseases/*immunology | 4 | 2.0 |
Cadherins/immunology | 5 | 38.0 |
Enzyme-Linked Immunosorbent Assay/methods | 5 | 1.0 |
Fluorescent Antibody Technique, Indirect | 8 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Pemphigus/*immunology | 15 | 36.0 |
Immunosorbent Techniques | 3 | 1.0 |
Pemphigus/blood/*immunology | 3 | 100.0 |
Antibody Specificity | 6 | 0.0 |
Immunoglobulin G/*immunology | 4 | 4.0 |
Autoantibodies/*blood | 7 | 2.0 |
Biological Markers/blood | 3 | 0.0 |
Severity of Illness Index | 2 | 0.0 |
Cytoskeletal Proteins/*immunology | 7 | 63.0 |
Immunophenotyping | 2 | 0.0 |
Cell Adhesion Molecules/genetics | 4 | 8.0 |
Cytoskeletal Proteins/genetics | 4 | 6.0 |
Immunoglobulin G/immunology | 4 | 1.0 |
Immunohistochemistry | 3 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Skin/immunology/pathology | 3 | 7.0 |
Cytoskeletal Proteins/*metabolism | 3 | 1.0 |
Microscopy, Electron | 4 | 0.0 |
Protein Binding | 4 | 0.0 |
Baculoviridae/genetics | 3 | 1.0 |
Cytoskeletal Proteins/genetics/*metabolism | 2 | 3.0 |
Epidermis/metabolism | 2 | 5.0 |
Immunoblotting | 14 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Cells, Cultured | 6 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Dogs | 4 | 0.0 |
Keratin/metabolism | 2 | 1.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Precipitin Tests | 4 | 0.0 |
Animals, Newborn | 4 | 0.0 |
Immunoglobulin G/blood | 3 | 1.0 |
Autoimmune Diseases/immunology | 2 | 2.0 |
Blotting, Western | 2 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
Autoantigens/*immunology | 8 | 4.0 |
Glucocorticoids/therapeutic use | 2 | 2.0 |
Prednisolone/therapeutic use | 2 | 2.0 |
Recombinant Proteins/immunology | 3 | 0.0 |
Cadherins/genetics/*immunology | 2 | 100.0 |
Lymphocyte Activation | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Desmosomes/*immunology | 5 | 83.0 |
Time Factors | 2 | 0.0 |
Base Sequence | 13 | 0.0 |
Gene Expression | 3 | 0.0 |
Autoantibodies/biosynthesis | 2 | 5.0 |
Desmosomes/chemistry | 2 | 25.0 |
Exons/genetics | 2 | 0.0 |
Mucous Membrane/immunology | 2 | 7.0 |
Pemphigus/*immunology/*pathology | 2 | 100.0 |
Autoantigens/*analysis | 3 | 14.0 |
Cadherins/*analysis/immunology | 2 | 66.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Membrane Glycoproteins/*genetics | 2 | 0.0 |
Pemphigus/etiology/*immunology | 2 | 100.0 |
Glycosylation | 2 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Carcinoma, Squamous Cell | 2 | 1.0 |
Cadherins/*genetics/immunology | 3 | 60.0 |
Mice, Transgenic | 2 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Autoantigens/metabolism | 2 | 4.0 |
Fluorescent Antibody Technique | 7 | 0.0 |
Pemphigus/immunology | 2 | 22.0 |
Cytoskeletal Proteins/*analysis | 2 | 12.0 |
Autoantibodies/immunology | 2 | 1.0 |
Skin/*immunology | 2 | 1.0 |
Cadherins/chemistry/*physiology | 2 | 50.0 |
Keratinocytes/physiology | 2 | 9.0 |
Molecular Probes/genetics | 2 | 2.0 |
Epitopes | 2 | 0.0 |
Autoantibodies/analysis | 3 | 1.0 |
Cadherins/*analysis | 2 | 9.0 |
Keratinocytes/immunology | 2 | 8.0 |
Polymerase Chain Reaction | 7 | 0.0 |
*Epitopes | 2 | 1.0 |
Molecular Conformation | 2 | 0.0 |
Pemphigus/*blood | 3 | 75.0 |
Cell Adhesion Molecules/chemistry | 2 | 14.0 |
Cattle | 4 | 0.0 |
*Chromosomes, Human, Pair 18 | 6 | 4.0 |
Cross Reactions | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Endemic Diseases | 2 | 12.0 |
Autoantigens/*genetics | 4 | 5.0 |
Cell Adhesion Molecules/*genetics | 2 | 2.0 |
Chromosome Mapping | 2 | 0.0 |
Pemphigus/genetics | 4 | 80.0 |
Hybrid Cells | 2 | 0.0 |
Oligodeoxyribonucleotides/genetics | 2 | 2.0 |
Pemphigus/*genetics | 2 | 33.0 |
Child | 2 | 0.0 |
Brazil | 2 | 0.0 |
Autoantibodies/blood | 2 | 1.0 |
